|
Activity Number:
|
494
|
|
Type:
|
Invited
|
|
Date/Time:
|
Thursday, August 7, 2008 : 10:30 AM to 12:20 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #300414 |
|
Title:
|
Practical Considerations in Exploratory Imaging
|
|
Author(s):
|
Haren Rupani*+
|
|
Companies:
|
Novartis Pharmaceuticals
|
|
Address:
|
1 Health Plaza, East hanover, NJ, 07936,
|
|
Keywords:
|
Exploratory imaging ; qualification ; biomarkers ; Oncology
|
|
Abstract:
|
In light of the current availability of functional and molecular imaging in addition to the traditional anatomic imaging modality for Oncology drug development, an exploratory imaging strategy is used to develop potentially useful biomarkers. The qualification of these biomarkers is actively being pursued through many public-private partnerships. The goal of this talk is to share the Novartis experience in using exploratory imaging in oncologic drug development.
|
